As if managing a disparate, 2500‐person cohort study in multiple locations isn’t enough of a challenge, consider the FDA’s requirement of ECG monitoring in all studies, some including holter and long‐term monitoring. It can be enough to cause you to turn to self‐medication.

The WaveWatch Group has over 50 years of experience in managing large and small group ECG overreads. We can build portals for your specific study group, and deliver ECG overreads on any schedule your study demands.

Located in Research Triangle Park, NC, the home to the largest CROs in the world, WaveWatch fully understands the challenges of pharma trials. With a strong background in FDA Phase II & III studies, and a Chief Medical Officer with a background in Epidemiology and Public Health, WaveWatch is the ideal partner when it comes to clinical trials.